THU0001 Differential Methylation as a Potential Biomarker of Methotrexate Response in Patients With Rheumatoid Arthritis

doi 10.1136/annrheumdis-2017-eular.6330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Effectiveness of Subcutaneously Administered Methotrexate in Patients With Rheumatoid Arthritis

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Can Methotrexate Prevent Knee Arthroplasties in Patients With Rheumatoid Arthritis?

Journal of Rheumatology
RheumatologyAllergyImmunology
2015English

Canadian Recommendations for Use of Methotrexate in Patients With Rheumatoid Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

Safety of Low Dose Methotrexate in Elderly Patients With Rheumatoid Arthritis

Postgraduate Medical Journal
Medicine
2000English

Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Genetic Polymorphisms in Key Methotrexate Pathway Genes Are Associated With Response to Treatment in Rheumatoid Arthritis Patients

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2012English

IgG Fc Galactosylation Predicts Response to Methotrexate in Early Rheumatoid Arthritis

Arthritis Research & Therapy
2017English

P141 Differential DNA Methylation in Peripheral naÏve CD4+T-cells in Early Rheumatoid Arthritis Patients

2019English

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-Α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients

Archivum Immunologiae et Therapiae Experimentalis
MedicineAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy